Form 4: USANA Health Sciences Inc: Chief Sales Officer David Mulham Reports Stock Transactions

David Mulham, Chief Sales Officer of USANA Health Sciences Inc, reports the acquisition of common stock through the vesting of restricted stock units on February 6th and 7th, 2025.

Summary

• David Mulham, the Chief Sales Officer of USANA Health Sciences Inc, filed a Form 4 detailing changes in beneficial ownership.
• On February 6, 2025, 2,377 shares of common stock were acquired through the vesting of restricted stock units.
• Following this transaction, Mulham directly owns 10,202 shares of common stock.
• On February 7, 2025, an additional 1,557 shares of common stock were acquired through the vesting of restricted stock units.
• Following this transaction, Mulham directly owns 11,759 shares of common stock.
• After these transactions, Mulham directly owns 18,280 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The vesting of restricted stock units indicates a continued investment in the company by a key executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may view insider transactions as a signal of management's confidence in the company.

Key Dates

Keywords

USANA Health Sciences, David Mulham, Chief Sales Officer, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Transactions, USNA